(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Chronic Lymphocytic Leukemia
Patients with active B-CLL and with an indication for treatment are asked to participate in this international, phase III clinical research study of an investigational agent.
Candidates 18 or older with tumor cell phenotype consistent with B-CLL who have failed at least one fludarabine-containing or alemtuzumab-containing treatment regimen may be eligible. Volunteers cannot have had previous treatment with alemtuzumab within six weeks of study participation or autologous stem cell transplantation within six months of the first study visit.
Research sites are worldwide.
This research study will evaluate the safety and effectiveness of a study drug in combination with high doses of inhaled steroids and long-acting bronchodilators for asthmatics who still have symptoms despite treatment with standard asthma drugs such as Advair. Asthmatics 18-75 who are currently using high doses of inhaled steroids and long-acting bronchodilators may qualify. This study involves up to 17 visits over one year.
The research site is in Denver, Colo.
Postmenopausal women with diagnosed osteoporosis may qualify for this research study. Candidates must not have taken Fosamax, Actonel, or Bonlva for osteoporosis. Participants receive at no cost study medications, physical exam and blood work, and reimbursement for time and travel.
The research site is in Philadelphia, Penn.
Copyright 2006 Thomson CenterWatch. All rights reserved.
Last reviewed: 08/07/2006 Last updated: 08/07/2006